CS
ACH

Candriam SCA’s Accendra Health ACH Stock Holding History

Candriam SCA’s Portfolio ACH Stock Details ACH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-33,879
Closed -$454K – 829
2023
Q1 		$454K Sell
33,879
-8,373
-20% -$150K ﹤0.01% 787
2022
Q4 		$825K Buy
42,252
+2,652
+7% +$51.7K 0.01% 744
2022
Q3 		$954K Buy
+39,600
New +$1.22M 0.01% 716

Other funds holding ACH

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Candriam SCA's ACH Position: Q2 2023 in Review

Candriam SCA sold out of Accendra Health (ACH) in Q2 2023, closing a stake of 33,879 shares — an estimated $454K sold.

Candriam SCA first reported a position in ACH in Q3 2022 and held it in 3 quarters. The position peaked at $954K in Q3 2022. 230 funds tracked by Wall St. Rank hold ACH as of Q2 2023.

  • Candriam SCA reported no remaining Accendra Health position as of Q2 2023 after selling out during the quarter.
  • Candriam SCA sold 33,879 Accendra Health shares in Q2 2023, an estimated $454K.
  • Candriam SCA first reported a position in Accendra Health in Q3 2022 and held it in 3 quarters.
  • Candriam SCA's Accendra Health position peaked at $954K in Q3 2022.
  • 230 funds tracked by Wall St. Rank held Accendra Health as of Q2 2023.

Based on Candriam SCA's 13F filing for Q2 2023, filed 8 Aug 2023.